Quantcast
 
Read Larry Connors' blogShort Term Trading Strategies


 

Misonix sells assets of Acoustic Marketing Research (Sonora Medical Systems) to Medical Imaging Holdings

Tue. October 06, 2009; Posted: 03:11 PM
Stocks RSS
Oct 06, 2009 (Datamonitor Financial Deals Tracker via COMTEX) -- MSON | Quote | Chart | News | PowerRating -- Misonix, Inc. has sold substantially all of the assets of its subsidiary, Acoustic Marketing Research, Inc. (doing business as Sonora Medical Systems, Inc.) to Medical Imaging Holdings, Inc. for $8 million in cash.

Misonix is a developer and manufacturer of therapeutic ultrasonic medical devices and laboratory equipment. Sonora Medical Systems is a developer and marketer of test equipment and biomedical tools for the ultrasound diagnostic imaging field and other specialty markets.

Medical Imaging Holdings is a holding company formed by healthcare private equity firm Galen Partners. All the companies involved in the transaction are based in the US.

Sonora Medical Systems business will be combined with the businesses of Barrington Medical Imaging and Echoserve, which were acquired by Medical Imaging Holdings on September 18, 2009.

Deal Value (US$ Million) 8
Deal Type                Acquisition
Sub-Category             Asset Purchase
Deal Status              Completed: 2009-10-05

Deal Participants

Target (Company)   Sonora Medical Systems, Inc. - Assets
Acquirer (Company) Medical Imaging Holdings, Inc.
Vendor (Company)   Misonix, Inc.

Deal Rationale

The acquisition will enable Medical Imaging Holdings to expand and further differentiate its service offerings and technical capabilities, as well as provide an advanced research and development capability for continued innovation. The sale of Sonora Medical Systems business will allow Misonix to accelerate the growth of its expanding therapeutic medical device business. These funds will be used for potential acquisitions of new products that can be sold together with its present products in its existing sales distribution, additional selling capability, product development, the licensing of new technology and general corporate purposes, among other uses.

For full details for MSON click here.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [MSON]
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.